Integra LifeSciences Holdings Corp. (IART) reported third quarter adjusted earnings per share of $0.80, compared to $0.68, last year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.53, for the quarter. Analysts' estimates typically exclude special items.
Third quarter reported revenues were $370.2 million, a decrease of 2.3% on a reported basis and a decrease of 1.5% on an organic basis compared to the prior year. Analysts expected revenue of $347.98 million, for the quarter.
Due to the ongoing uncertainty related to the pandemic, the company's guidance for the full-year 2020 remains withdrawn.
"Better than expected performance in the third quarter was driven by stronger recovery trends and solid execution across the organization. Barring significant worsening of the pandemic, we believe these efforts will result in a further sequential revenue improvement in the fourth quarter," said Peter Arduini, Integra's CEO.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.